In last trading session, Replimune Group Inc (NASDAQ:REPL) saw 0.67 million shares changing hands with its beta currently measuring 1.29. Company’s recent per share price level of $13.98 trading at -$0.33 or -2.31% at ring of the bell on the day assigns it a market valuation of $1.08B. That closing price of REPL’s stock is at a discount of -21.6% from its 52-week high price of $17.00 and is indicating a premium of 64.81% from its 52-week low price of $4.92.
For Replimune Group Inc (REPL), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.12. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.69 in the current quarter.
Replimune Group Inc (NASDAQ:REPL) trade information
Upright in the red during last session for losing -2.31%, in the last five days REPL remained trading in the red while hitting it’s week-highest on Friday, 02/21/25 when the stock touched $13.98 price level, adding 5.54% to its value on the day. Replimune Group Inc’s shares saw a change of 15.44% in year-to-date performance and have moved -2.17% in past 5-day. Replimune Group Inc (NASDAQ:REPL) showed a performance of 7.37% in past 30-days.
Wall Street analysts have assigned a consensus price target of 23 to the stock, which implies a rise of 39.22% to its current value. Analysts have been projecting 19 as a low price target for the stock while placing it at a high target of 27. It follows that stock’s current price would drop -35.91% in reaching the projected high whereas dropping to the targeted low would mean a loss of -35.91% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -19.52% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 13.39% while estimates for its earnings growth in next 5 years are of 13.91%.
Replimune Group Inc (NASDAQ:REPL)’s Major holders
BAKER BROS. ADVISORS LP is the top institutional holder at REPL for having 10.05 million shares of worth $90.41 million. And as of 2024-06-30, it was holding 14.5193 of the company’s outstanding shares.
The second largest institutional holder is PRICE T ROWE ASSOCIATES INC /MD/, which was holding about 9.24 million shares on 2024-06-30. The number of shares represents firm’s hold over 13.8742 of outstanding shares, having a total worth of $83.13 million.
On the other hand, Price (T.Rowe) New Horizons Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 4.39 shares of worth $61.41 million or 5.70% of the total outstanding shares. The later fund manager was in possession of 2.02 shares on Sep 30, 2024 , making its stake of worth around $28.29 million in the company or a holder of 2.63% of company’s stock.
